SOURCE: BIO-key International, Inc.

BIO-key International, Inc.

August 13, 2012 08:00 ET

BIO-key® International, Inc. Presenting Fingerprint Biometric Authentication Solution for EHR & ePrescriptions at Allscripts Client Experience (ACE)

WALL, NJ--(Marketwire - Aug 13, 2012) -   BIO-key International, Inc. (OTCBB: BKYI), a global leader in fingerprint biometric identification solutions and advanced mobile identification technology, today reported that the company will be presenting the latest advances in fingerprint biometric authentication technology at the Allscripts Client Experience (ACE) taking place at the McCormick Center, in Chicago, IL on Wednesday, August 15th - 17th Booth # 448.

Ed Black, Director of Healthcare Solutions, will co-host a presentation with Allscripts, demonstrating how BIO-key technology enables hospital and clinic staff members to increase time spent caring for patients by streamlining the process for accessing and updating patient records. The presentation will also include information about how BIO-key technology raises the level of security, while offering a complete solution that meets the DEA and State Board of Pharmacy requirements for two-factor authentication.

Mr. Black will join John Judd, Manager, Product Management of Allscripts, on Friday, August 17th at 10:15am to share their experiences working with leading hospitals and clinics that are seeking to achieve optimum efficiency and security for EHR processes. 

At this year's ACE event, BIO-key will debut a new tool which measures the amount of time hospitals will save when they streamline the log-in process by incorporating BIO-key's technology.

"We have achieved measureable results helping Allscripts customers increase convenience by reducing or eliminating the need for entering sophisticated passwords. When measured, across departments the savings is quite significant," said Scott Mahnken, Vice President of Marketing. "With the recent changes in the biometric industry and the popularity of the iPad in healthcare, fingerprint biometric technology is ideally positioned as the solution to provide secure and convenient access to applications of all types," added Mahnken.

About BIO-key
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (

BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2011 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.

Contact Information

  • Contacts:
    BIO-key International, Inc.
    Scott Mahnken